Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Macrophage reprogramming, not CD8 T cell dynamics, characterizes durable disease control following PD-1 blockade in smoldering myeloma.
Journal: Leukemia
Published: May 09, 2026
A review of the clinical efficacy of monoclonal antibody (mAb)-based therapies for relapsed/refractory multiple myeloma (RRMM).
Journal: Expert opinion on biological therapy
Published: March 17, 2026
Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.
Journal: Haematologica
Published: March 12, 2026
Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myeloma.
Journal: Bone marrow transplantation
Published: January 21, 2026
Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy.
Journal: The New England journal of medicine
Published: August 20, 2025
Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study.
Journal: Nature communications
Published: August 01, 2025
Precursor plasma cell disorders: Classification, risk stratification, and emerging role of early interception.
Journal: Best practice & research. Clinical haematology
Published: February 17, 2025
Impact of Prior Selinexor Exposure on Outcomes of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Exploratory Analysis.
Journal: Journal of clinical medicine
Published: December 22, 2024
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma.
Journal: Bone marrow transplantation
Published: November 26, 2024
Advancements in bispecific antibodies for multiple myeloma: What's new and what lies ahead.
Journal: Seminars in hematology
Published: October 14, 2024
Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical Trials.
Journal: Clinical lymphoma, myeloma & leukemia
Published: August 06, 2024
Last Updated: 09/26/2026